Correlation Between Merck and Rain Therapeutics
Can any of the company-specific risk be diversified away by investing in both Merck and Rain Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Rain Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Rain Therapeutics, you can compare the effects of market volatilities on Merck and Rain Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Rain Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Rain Therapeutics.
Diversification Opportunities for Merck and Rain Therapeutics
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Merck and Rain is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Rain Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rain Therapeutics and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Rain Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rain Therapeutics has no effect on the direction of Merck i.e., Merck and Rain Therapeutics go up and down completely randomly.
Pair Corralation between Merck and Rain Therapeutics
If you would invest 141.00 in Rain Therapeutics on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Rain Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 2.27% |
Values | Daily Returns |
Merck Company vs. Rain Therapeutics
Performance |
Timeline |
Merck Company |
Rain Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Merck and Rain Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Merck and Rain Therapeutics
The main advantage of trading using opposite Merck and Rain Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Rain Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rain Therapeutics will offset losses from the drop in Rain Therapeutics' long position.The idea behind Merck Company and Rain Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Rain Therapeutics vs. Ocean Biomedical | Rain Therapeutics vs. Enveric Biosciences | Rain Therapeutics vs. Elevation Oncology | Rain Therapeutics vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |